Peter Salzmann, CEO, Director at Immunovant, holds 994.79K shares in Immunovant (Ticker: IMVT), holds 2.78K shares in Corbus Pharmaceuticals (Ticker: CRBP). Most recently, Peter Salzmann Sold ― shares of Immunovant on Oct 18, 2024 for an estimated value of 261.85K.
What is the percentage of profitable transactions made by Peter Salzmann?
The percentage of profitable transactions made by Peter Salzmann is 22%.
What is the average return per transaction made by Peter Salzmann?
The average return per transaction made by Peter Salzmann is -126.30%.
What stocks does Peter Salzmann hold?
Peter Salzmann holds: IMVT, CRBP stocks.
What was Peter Salzmann’s latest transaction?
Peter Salzmann latest transaction was an Informative Sell of $261.85K.
What was Peter Salzmann's most profitable transaction?
Peter Salzmann’s most profitable transaction was an Informative Sell of IMVT stock on January 9, 2024. The return on the trade was 30.00%.
What is Peter Salzmann's role in Immunovant?
Peter Salzmann's role in Immunovant is CEO, Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.